Eperisone
Phase 3Completed 0 views this week 0 watching⚡ Active
Interest: 40/100
40
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 24
Phase 35
ApprovedIndication / Disease
Muscle Spasm; Back Pain
Conditions
Muscle Spasm; Back Pain
Trial Timeline
Apr 1, 2006 → Jun 1, 2006
NCT ID
NCT00327730About Eperisone
Eperisone is a phase 3 stage product being developed by Eisai for Muscle Spasm; Back Pain. The current trial status is completed. This product is registered under clinical trial identifier NCT00327730. Target conditions include Muscle Spasm; Back Pain.
What happened to similar drugs?
1 of 20 similar drugs in Muscle Spasm; Back Pain were approved
Approved (1) Terminated (0) Active (19)
Hype Score Breakdown
Clinical
17
Activity
8
Company
15
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00327730 | Phase 3 | Completed |
Competing Products
20 competing products in Muscle Spasm; Back Pain